Interlaboratory variation in antiphospholipid antibody testing

Alan M Peaceman*, Richard K. Silver, Scott N. MacGregor, Michael L Socol

*Corresponding author for this work

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

OBJECTIVE: Because of the widespread use of antiphospholipid antibody testing in the evaluation of patients with recurrent pregnancy loss, we evaluated the consistency of results among laboratories testing for anticardiolipin antibody and the lupus anticoagulant. STUDY DESIGN: A questionnaire regarding methods used and samples of blood from 20 patients were sent to five university-based and five commercial facilities for antiphospholipid antibody testing. RESULTS: The responses of the participating laboratories to the questionnaires revealed significant differences in methods, standardization, and units of reporting. For anticardiolipin antibody, the number of specimens found to be positive for any isotype (immunoglobulin G, M, or A) varied considerably among laboratories, with a range of 5 to 13. All laboratories were in agreement (i.e., at least one isotype was present or all were absent) for only 5 of 20 specimens (25%). In contrast, lupus anticoagulant results were more reproducible, although one facility reported results markedly discordant from the other four laboratories. CONCLUSION: These observations suggest that significant interlaboratory variation exists in antiphospholipid antibody, and particularly anticardiolipin antibody, testing and might lead to unnecessary therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)1780-1787
Number of pages8
JournalAmerican Journal of Obstetrics and Gynecology
Volume166
Issue number6 PART 1
DOIs
StatePublished - Jan 1 1992

Fingerprint

Antiphospholipid Antibodies
Anticardiolipin Antibodies
Lupus Coagulation Inhibitor
Immunoglobulin A
Immunoglobulin M
Immunoglobulin G
Pregnancy

Keywords

  • Antiphospholipid antibodies
  • anticardiolipin antibody
  • lupus anticoagulant
  • recurrent pregnancy loss

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Peaceman, Alan M ; Silver, Richard K. ; MacGregor, Scott N. ; Socol, Michael L. / Interlaboratory variation in antiphospholipid antibody testing. In: American Journal of Obstetrics and Gynecology. 1992 ; Vol. 166, No. 6 PART 1. pp. 1780-1787.
@article{8922de8380ff4e01afdc725f4dfa8990,
title = "Interlaboratory variation in antiphospholipid antibody testing",
abstract = "OBJECTIVE: Because of the widespread use of antiphospholipid antibody testing in the evaluation of patients with recurrent pregnancy loss, we evaluated the consistency of results among laboratories testing for anticardiolipin antibody and the lupus anticoagulant. STUDY DESIGN: A questionnaire regarding methods used and samples of blood from 20 patients were sent to five university-based and five commercial facilities for antiphospholipid antibody testing. RESULTS: The responses of the participating laboratories to the questionnaires revealed significant differences in methods, standardization, and units of reporting. For anticardiolipin antibody, the number of specimens found to be positive for any isotype (immunoglobulin G, M, or A) varied considerably among laboratories, with a range of 5 to 13. All laboratories were in agreement (i.e., at least one isotype was present or all were absent) for only 5 of 20 specimens (25{\%}). In contrast, lupus anticoagulant results were more reproducible, although one facility reported results markedly discordant from the other four laboratories. CONCLUSION: These observations suggest that significant interlaboratory variation exists in antiphospholipid antibody, and particularly anticardiolipin antibody, testing and might lead to unnecessary therapeutic interventions.",
keywords = "Antiphospholipid antibodies, anticardiolipin antibody, lupus anticoagulant, recurrent pregnancy loss",
author = "Peaceman, {Alan M} and Silver, {Richard K.} and MacGregor, {Scott N.} and Socol, {Michael L}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0002-9378(92)91569-V",
language = "English (US)",
volume = "166",
pages = "1780--1787",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6 PART 1",

}

Interlaboratory variation in antiphospholipid antibody testing. / Peaceman, Alan M; Silver, Richard K.; MacGregor, Scott N.; Socol, Michael L.

In: American Journal of Obstetrics and Gynecology, Vol. 166, No. 6 PART 1, 01.01.1992, p. 1780-1787.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interlaboratory variation in antiphospholipid antibody testing

AU - Peaceman, Alan M

AU - Silver, Richard K.

AU - MacGregor, Scott N.

AU - Socol, Michael L

PY - 1992/1/1

Y1 - 1992/1/1

N2 - OBJECTIVE: Because of the widespread use of antiphospholipid antibody testing in the evaluation of patients with recurrent pregnancy loss, we evaluated the consistency of results among laboratories testing for anticardiolipin antibody and the lupus anticoagulant. STUDY DESIGN: A questionnaire regarding methods used and samples of blood from 20 patients were sent to five university-based and five commercial facilities for antiphospholipid antibody testing. RESULTS: The responses of the participating laboratories to the questionnaires revealed significant differences in methods, standardization, and units of reporting. For anticardiolipin antibody, the number of specimens found to be positive for any isotype (immunoglobulin G, M, or A) varied considerably among laboratories, with a range of 5 to 13. All laboratories were in agreement (i.e., at least one isotype was present or all were absent) for only 5 of 20 specimens (25%). In contrast, lupus anticoagulant results were more reproducible, although one facility reported results markedly discordant from the other four laboratories. CONCLUSION: These observations suggest that significant interlaboratory variation exists in antiphospholipid antibody, and particularly anticardiolipin antibody, testing and might lead to unnecessary therapeutic interventions.

AB - OBJECTIVE: Because of the widespread use of antiphospholipid antibody testing in the evaluation of patients with recurrent pregnancy loss, we evaluated the consistency of results among laboratories testing for anticardiolipin antibody and the lupus anticoagulant. STUDY DESIGN: A questionnaire regarding methods used and samples of blood from 20 patients were sent to five university-based and five commercial facilities for antiphospholipid antibody testing. RESULTS: The responses of the participating laboratories to the questionnaires revealed significant differences in methods, standardization, and units of reporting. For anticardiolipin antibody, the number of specimens found to be positive for any isotype (immunoglobulin G, M, or A) varied considerably among laboratories, with a range of 5 to 13. All laboratories were in agreement (i.e., at least one isotype was present or all were absent) for only 5 of 20 specimens (25%). In contrast, lupus anticoagulant results were more reproducible, although one facility reported results markedly discordant from the other four laboratories. CONCLUSION: These observations suggest that significant interlaboratory variation exists in antiphospholipid antibody, and particularly anticardiolipin antibody, testing and might lead to unnecessary therapeutic interventions.

KW - Antiphospholipid antibodies

KW - anticardiolipin antibody

KW - lupus anticoagulant

KW - recurrent pregnancy loss

UR - http://www.scopus.com/inward/record.url?scp=0026735190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026735190&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(92)91569-V

DO - 10.1016/0002-9378(92)91569-V

M3 - Article

VL - 166

SP - 1780

EP - 1787

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6 PART 1

ER -